Coverage at a glance
| Indication | Coverage |
|---|---|
| Type 2 diabetes | Varies by plan |
Plan type: Medicare Part D. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
Coverage by indication
What the prior authorization needs:
- Coverage and cost tier vary by the specific Humana Medicare plan.
- On 2026 plans that list Rybelsus it sits on tier 3 (HumanaChoice PPO) or tier 2 (Humana Medicare employer plan) with no prior authorization, step therapy, or quantity limit.
- Some Humana Part D drug lists, including the Basic Rx PDP and the Value Rx PDP, do not list Rybelsus at all.
- Members should confirm coverage on their own plan's drug list before filling.
Policy Y0040_PDG26_FINAL_15C_C. Source: 2026 Prescription Drug Guide, HumanaChoice (PPO) / Humana Value Choice (PPO), Humana Formulary (Y0040_PDG26_FINAL_15C_C, doc 20260015PDG2640826C, updated 08/01/2026). payer-formulary. Verified August 27, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time. Some participants get a placebo, decided at random.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Humana cover Rybelsus?
Humana is a Medicare plan, and some of its Part D drug lists cover Rybelsus for type 2 diabetes, but the tier and rules vary by plan. On 2026 plans that list it, such as HumanaChoice (PPO), Rybelsus sits on tier 3 with no prior authorization, step therapy, or quantity limit; some Humana employer plans place it on tier 2, and a few Part D drug lists (for example the Basic Rx and Value Rx PDPs) do not list it at all. Medicare does not cover Rybelsus for weight loss, and Rybelsus has no weight-loss indication. Wegovy is the semaglutide approved for weight loss. This reflects the published policy verified August 2026.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
